Career history of Nicholas Vlahakis
Former positions of Nicholas Vlahakis
| Companies | Position | Start | End |
|---|---|---|---|
| COHBAR, INC. | Chief Tech/Sci/R&D Officer | 01/01/2022 | 01/05/2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Training of Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Statistics
International
| United States | 4 |
| Australia | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Nicholas Vlahakis
- Experience
